LAVAL, QC, Oct. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will releas

ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility

BHC, CDNA, DOLE and CHEF offer defensive exposure as consumer confidence falls amid inflation and ge

Bristol Myers Squibb (NYSE: BMY - Get Free Report) and Bausch Health Cos (NYSE: BHC - Get Free Repor

BHC, OPHC and TRVG made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 22nd, 20

Bausch Health Cos Inc. (NYSE: BHC - Get Free Report) has been given a consensus rating of "Reduce" b

Engineers Gate Manager LP grew its holdings in Bausch Health Cos Inc. (NYSE: BHC) by 149.6% in the u

Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks poste

AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for

Collaboration expands access to science-led, microbiome-friendly skincare solutions in Mexico and ac

This year's Aspire Higher scholarships are awarded to six students who have been affected by dermato

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, a

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the compa

Bausch + Lomb is positioned as a turnaround and deleveraging opportunity, benefiting from a shift to

Paulson's hedge fund reduced its equity book to $2.58B in Q2, exiting two positions and opening

For the Seventh Consecutive Year, 10 Students with Gastrointestinal Disease  Will Each Receive a $10

Bausch Health Companies Inc. has surged 40% post-Q2 on strong results and raised FY2026 guidance, bu

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Investors were cheered by the beat-and-raise second quarter. The company also had good news to repor

LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular

Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion t

Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the anal

PrOKEDI® is a prolonged-release injectable suspension of risperidone indicated for the treatment of

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announce

Thermage®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certi

Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the ana

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perf

Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight

Bausch Health Companies (NYSE:BHC) sees FY2026 sales of $10.625 billion-$10.875 billion vs $10.595 b

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.10 per share which missed the a

https://ag.ny.gov/press-release/2026/attorney-general-james-secures-more-17-million-drug-manufacture

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 

Truist Securities analyst Les Sulewski maintains Bausch Health Companies (NYSE:BHC) with a Hold a

Barclays analyst Glen Santangelo initiates coverage on Bausch Health Companies (NYSE:BHC) with a

The Shibo group has served as Solta Medical's trusted distribution partner over the past decade.

Carl Icahn's empire, IEP, has collapsed 80% due to Hindenburg's short-selling attack. Icahn&

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.16 per share which beat the ana

Bausch Health Companies (NYSE:BHC) raises FY2025 sales outlook from $10.000 billion-$10.250 billion